Skip to main content

Table 3 Multivariate analysis of independent prediction of silent liver fibrosis

From: Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

  Odds ratio 95% Confidentialinterval P-value
Laboratory variables    
Gamma-glutamyltranspeptidase, IU/L 1.009 0.953, 1.068 0.757
Cumulative dose of medications, mg    
Leflunomide (53 patients) 1.000 1.000, 1.000 0.007
Prednisolone (89 patients) 1.000 1.000, 1.000 0.547